These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

704 related items for PubMed ID: 11488259

  • 1. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B, Bonnet-Perrin E.
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [Abstract] [Full Text] [Related]

  • 2. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
    Tollefson GD, Birkett M, Koran L, Genduso L.
    J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
    [Abstract] [Full Text] [Related]

  • 3. Predictors of drug treatment response in obsessive-compulsive disorder.
    Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G.
    J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E, Mullen L, DeCaria CM, Skodol A, Schneier FR, Liebowitz MR, Klein DF.
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fluoxetine treatment of obsessive-compulsive disorder: an open clinical trial.
    Liebowitz MR, Hollander E, Schneier F, Campeas R, Hatterer J, Papp L, Fairbanks J, Sandberg D, Davies S, Stein M.
    J Clin Psychopharmacol; 1989 Dec; 9(6):423-7. PubMed ID: 2687337
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
    Rabinowitz I, Baruch Y, Barak Y.
    Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine.
    Mundo E, Rouillon F, Figuera ML, Stigler M.
    Hum Psychopharmacol; 2001 Aug; 16(6):461-468. PubMed ID: 12404554
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.